1. Will there ever be a European drug pricing and reimbursement agency?

   • M. F. Drummond

   Editorial Pages: 67 - 69

2. Modeling the cost-effectiveness and budgetary impact for subpopulations

   • M. J. C. Nuijten
   • J. Kosa
   • P. Engelfriet

   Original Papers Pages: 70 - 78

3. Public health insurance Pareto-efficient allocative improvements through differentiated copayment rates

   • R. Osterkamp

   Original Papers Pages: 79 - 84

4. Length of hospital stay and associated costs for olanzapine vs. haloperidol in the treatment of schizophrenia relapse in Germany

   • A. Spannheimer
   • U. Reitberger
   • M. Lothgren

   Original Papers Pages: 85 - 89

5. Theory verses empiricism in health economics

   • J. F. P. Bridges
   • P. Haywood

   Original Papers Pages: 90 - 95

6. Influence of surgical and treatment choices on the cost of breast cancer care

   • C. J. Bradley
   • C. Given
   • J. Gardiner

   Original Papers Pages: 96 - 101

7. Cost of diagnostic and therapeutic management of colorectal cancer according to stage at diagnosis in the Calvados Département, France

   • V. Bouvier
   • J.-M. Reaud
   • G. Launoy

   Original Papers Pages: 102 - 106

8. Health-based risk adjustment Improving the pharmacy-based cost group

   • L. M. Lamers
   • R. C. J. A. Vliet

   Original Papers Pages: 107 - 114

9. Changes in cost-effectiveness over time

   • E. Remák
   • J. Hutton
   • M. Zagari

   Original Papers Pages: 115 - 121

10. Metal on metal hip resurfacing arthroplasty

    • L. McKenzie
    • L. Vale
    • K. McCormack

    Original Papers Pages: 122 - 129

11. Cost-effectiveness analysis of two strategies for typing unrelated donors for bone marrow transplantation in France

    • D. Berchery
    • L. Molinier
    • A. Cambon-Thomsen

    Original Papers Pages: 130 - 137